Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03872505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence
ClinicalTrials.gov study NCT04874064. IPD Sharing: NO. Countries: 1. Publications: 0.
Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05485766. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02826434. IPD Sharing: NO. Countries: 1. Publications: 0.
Sacituzumab Tirumotecan Plus Tagitanlimab in Previously Treated Locally Advanced or Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT07153965. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06926920. IPD Sharing: NO. Countries: 3. Publications: 0.
A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05692661. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT06690840. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
ClinicalTrials.gov study NCT02850302. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT05128734. IPD Sharing: NO. Countries: 1. Publications: 0.
LAG3 Expression in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06259162. IPD Sharing: NO. Countries: 1. Publications: 0.
Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03055312. IPD Sharing: NO. Countries: 1. Publications: 0.
LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06831955. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02926690. IPD Sharing: NO. Countries: 1. Publications: 0.
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
ClinicalTrials.gov study NCT06387628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003)
ClinicalTrials.gov study NCT06829199. IPD Sharing: YES. Countries: 2. Publications: 0.
Tracking Triple-negative Breast Cancer Evolution Through Therapy
ClinicalTrials.gov study NCT03077776. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT03348098. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05914961. IPD Sharing: NO. Countries: 1. Publications: 0.
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05318469. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.